• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Vireo Growth Authorizes Share Buyback Program

MINNEAPOLIS – Vireo Growth Inc. has received board approval to begin a share repurchase plan under a normal course issuer bid. Following a series of strategic moves, including an expansion into Ohio and an earlier ...

Organigram Reports Q3 Fiscal 2026 Financial Results

TORONTO – Organigram Global Inc. released its third-quarter fiscal 2026 results, showing the first full contribution from its recent European acquisition alongside continued strength in the Canadian market. The company reported higher sales and adjusted ...

Curaleaf States Intention to Bid for Aurora Cannabis

STAMFORD – Curaleaf Holdings Inc. has publicly outlined plans to purchase all of the issued and outstanding common shares of Aurora Cannabis Inc., moving the proposal directly to shareholders after earlier private outreach. The announcement ...

Vireo Growth Reports Q2 2026 Financial Results

MINNEAPOLIS – Vireo Growth Inc. reported GAAP revenue of $209.3 million for the three months ended June 30, 2026, up 335% year-over-year from $48.1 million in Q2 2025, driven by the Eaze, Hawthorne Gardening Company, ...

High-Potency Cannabis Strains Impact Legal and Health Systems

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

MJ and MSOS ETFs Signal High Upside on U.S. Legalization Outlook

LOS ANGELES- Investment in cannabis-focused ETFs such as Amplify’s MJ and AdvisorShares’ MSOS reflects growing investor anticipation of federal legalization-driven expansion, even amid pronounced volatility and structural headwinds. Analysts argue that rescheduling cannabis from Schedule I ...

Canadian Cannabis Producers Expand Exports

LOS ANGELES- Canada’s licensed cannabis sector continues its move toward international markets, driven by strong global demand, especially for medical cannabis. During the 2023–24 fiscal year, Canada exported approximately CA$218 million of medical cannabis for commercial ...

Emerging Programs Aim to Democratize Cannabis Cultivation

LOS ANGELES- Governments, industry groups, and educational institutions are launching a wave of initiatives aimed at lowering barriers to entry in cannabis cultivation and production—efforts collectively referred to as “democratizing cannabis production.” These programs focus ...

Subscribe To Our Newsletter

Go to Top